PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

K Pharma,Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

K Pharma,Inc. made a loss over the last year. K Pharma,Inc. owes ¥0.70 for every ¥1 it owns. K Pharma,Inc. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

Loss

K Pharma,Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

10.49

The share price is 10.49 times K Pharma,Inc.'s book value per share, higher than 97% of Healthcare companies in Japan.

Market cap

¥8.1 B

The total market value of all of K Pharma,Inc.'s shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥774 M

What K Pharma,Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥66.56

Net worth divided by the number of shares. The share price of ¥698.00 is 10.5 times this, which is the P/B above.

Return on equity (ROE)

-80.5%

K Pharma,Inc. lost 80.5% of its shareholders' money over the last year, lower than 96% of Healthcare companies in Japan.

Owes vs Owns

0.70×

K Pharma,Inc. owes ¥0.70 for every ¥1 it owns (moderate), higher than 85% of Healthcare companies in Japan.

Dividend yield

None

K Pharma,Inc. does not currently pay a dividend.

Profit growth

Loss

K Pharma,Inc. made a loss in each of the last two years.

Interest cover

Not covered

K Pharma,Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

K Pharma,Inc. held ¥1.3 B more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For K Pharma,Inc.: ¥8.1 B ÷ ¥774 M (30 Jun 2026) = 10.5.

What is K Pharma,Inc.'s return on equity?

K Pharma,Inc. lost 80.5% of its shareholders' money over the last year, lower than 96% of Healthcare companies in Japan.

How much does K Pharma,Inc. owe compared with what it owns?

K Pharma,Inc. owes ¥0.70 for every ¥1 it owns (moderate), higher than 85% of Healthcare companies in Japan.

Does K Pharma,Inc. pay a dividend?

No. K Pharma,Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.